Dr Patrick Myers was co-author of a letter, published in the Lancet, on the recent EXPLORER-HCM randomised controlled trial of Mavacamten for the medical treatment of hypertrophic cardiomyopathy. This letter was a collaboration with surgeons from Barcelona, Spain and Pittsburgh, United States.
You can access the article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32384-9/fulltext